Summary
MediciNova, Inc. (MediciNova) is a biopharmaceutical company, which focuses on acquiring, developing and commercializing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs such as MN-001, for the treatment of nonalcoholic steatohepatitis; MN-166, for neurological disorders; and MN-221, for respiratory diseases. The company’s non-core programs include MN-001 being developed for two indications, namely, bronchial asthma and interstitial cystitis; MN-029 for the treatment of cancer; and MN-221 for the treatment of preterm labor. It has partnerships with various companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd and Meiji Seika Kaisha Ltd., to develop and commercialize its products. MediciNova is headquartered in San Diego, California, the US.
MediciNova, Inc. (MNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MediciNova, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
MediciNova, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MediciNova Forms Joint Venture With Zhejiang Medicine 10
Licensing Agreements 12
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 12
Equity Offering 13
MediciNova Raises USD17.5 Million in Public Offering of Shares 13
MediciNova Completes First Tranche Of Public Offering Of Common Stock For US$2.8 Million 15
MediciNova Completes First Tranche Of Private Placement Of Common Stock For US$1 Million 16
MediciNova Terminates Public Offering Of Common Stock For US$15 Million 18
MediciNova Completes Private Placement Of Common Stock And Preferred Stock For US$7.5 Million 20
MediciNova Completes An Underwritten Public Offering Of Units For US$8.4 Million 22
MediciNova Completes Private Placement Of US$9.5 Million 24
MediciNova, Inc. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
MediciNova, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MediciNova, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MediciNova, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
MediciNova Forms Joint Venture With Zhejiang Medicine 10
MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast 12
MediciNova Raises USD17.5 Million in Public Offering of Shares 13
MediciNova Completes First Tranche Of Public Offering Of Common Stock For US$2.8 Million 15
MediciNova Completes First Tranche Of Private Placement Of Common Stock For US$1 Million 16
MediciNova Terminates Public Offering Of Common Stock For US$15 Million 18
MediciNova Completes Private Placement Of Common Stock And Preferred Stock For US$7.5 Million 20
MediciNova Completes An Underwritten Public Offering Of Units For US$8.4 Million 22
MediciNova Completes Private Placement Of US$9.5 Million 24
MediciNova, Inc., Key Competitors 26
MediciNova, Inc., Key Employees 27
MediciNova, Inc., Subsidiaries 28
List of Figures
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MediciNova, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8